SEC Form 4 research
| Issuer | Wize Pharma, Inc. |
|---|---|
| Tickers | WIZP, OPLI, DCMG, MIGI, BGDE |
| Reporting owners | 47 |
| Officers and directors | 10 |
| Last public filing | 2026-09-24 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-23 | 2026-09-21 | Endeavor Blockchain, LLC, Kilgore Joshua Allen, PM Squared LLC, Six Thirty AI, LLC, Smith Cody | P | 795 | $6.21 | Not reported |
| 2026-09-23 | 2026-09-21 | Endeavor Blockchain, LLC, Kilgore Joshua Allen, PM Squared LLC, Six Thirty AI, LLC, Smith Cody | A | 442,899 | $5.8 | Not reported |
| 2026-09-22 | 2026-09-18 | Endeavor Blockchain, LLC, Kilgore Joshua Allen, PM Squared LLC, Six Thirty AI, LLC, Smith Cody | P | 494 | $5.99 | Not reported |
| 2026-09-18 | 2026-09-15 | Endeavor Blockchain, LLC, Kilgore Joshua Allen, PM Squared LLC, Six Thirty AI, LLC, Smith Cody | P | 1,325 | $5.99 | Not reported |
| 2026-09-15 | 2026-09-14 | Endeavor Blockchain, LLC, Kilgore Joshua Allen, PM Squared LLC, Six Thirty AI, LLC, Smith Cody | P | 151 | $6.55 | Not reported |
| 2026-09-15 | 2026-09-14 | Endeavor Blockchain, LLC, Kilgore Joshua Allen, PM Squared LLC, Six Thirty AI, LLC, Smith Cody | P | 152 | $6.43 | Not reported |
| 2026-09-15 | 2026-09-14 | Endeavor Blockchain, LLC, Kilgore Joshua Allen, PM Squared LLC, Six Thirty AI, LLC, Smith Cody | P | 152 | $6.55 | Not reported |
| 2026-09-15 | 2026-09-14 | Endeavor Blockchain, LLC, Kilgore Joshua Allen, PM Squared LLC, Six Thirty AI, LLC, Smith Cody | P | 152 | $6.42 | Not reported |
| 2026-09-15 | 2026-09-14 | Endeavor Blockchain, LLC, Kilgore Joshua Allen, PM Squared LLC, Six Thirty AI, LLC, Smith Cody | P | 152 | $6.51 | Not reported |
| 2026-09-15 | 2026-09-14 | Endeavor Blockchain, LLC, Kilgore Joshua Allen, PM Squared LLC, Six Thirty AI, LLC, Smith Cody | P | 153 | $6.47 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.